Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Heidelberg Retina Tomograph (HRT) in Vivo Confocal Microscopy to Evaluate the Ocular Surface Disorders of Healthy and Diseased Individuals

NCT04025801 is registered in ClinicalTrials.gov with National Taiwan University Hospital as lead sponsor.

NCT NCT04025801
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04025801 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Heidelberg Retina Tomograph (HRT) in Vivo Confocal Microscopy to Evaluate the Ocular Surface Disorders of Healthy and Diseased Individuals
Lead sponsor
National Taiwan University Hospital
Phase
Observational
Overall status
Unknown status
Start date
July 31, 2019
Completion date
June 30, 2020
Enrollment
400 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alzheimer disease, dementia, diabetes, dry eye syndrome, fabry disease, graft versus host disease in eye, healthy individuals, hypertension, limbal insufficiency, metabolic disease, ocular rosacea, phlyctenulosis